Altogether, we found that the P144 TGF‐β1 inhibitory peptide decreased renal fibrosis through the blockade of the TGF‐β1–Smad3 signaling pathway and the modulation of macrophage polarization, suggesting its potential therapeutic use in IRI‐induced renal fibrosis. This evidence concerns the gene SMAD3 and renal fibrosis.